The Food and Drug Administration is changing how it handles COVID-19 vaccines starting this fall, limiting access to older ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

World Health Organization (WHO) member countries adopted a new treaty on May 20, 2025, to improve international coordination ...

I'm a clinical academic, which is quite a rare breed of doctor, because what I'm doing, along with other clinical academics, ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...

The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults.

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.

Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...